Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment - PubMed (original) (raw)
. 2005 Nov 15;65(22):10164-9.
doi: 10.1158/0008-5472.CAN-05-2497.
Kevin M Brown, Lynda Chin, Dawn A Kirschmann, William W Wheaton, Alexei Protopopov, Bin Feng, Yoganand Balagurunathan, Jeffrey M Trent, Brian J Nickoloff, Richard E B Seftor, Mary J C Hendrix
Affiliations
- PMID: 16288000
- DOI: 10.1158/0008-5472.CAN-05-2497
Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment
Elisabeth A Seftor et al. Cancer Res. 2005.
Abstract
The clinical management of cutaneous melanoma would benefit significantly from a better understanding of the molecular changes that occur during melanocytic progression to a melanoma phenotype. To gain unique insights into this process, we developed a three-dimensional in vitro model that allows observations of normal human melanocytes interacting with a metastatic melanoma matrix to determine whether these normal cells could be reprogrammed by inductive cues in the tumor cell microenvironment. The results show the epigenetic transdifferentiation of the normal melanocytic phenotype to that of an aggressive melanoma-like cell with commensurate increased migratory and invasive ability with no detectable genomic alterations. Removal of the transdifferentiated melanocytes from the inductive metastatic melanoma microenvironment results in a reversion to their normal phenotype. However, a normal melanocyte microenvironment had no epigenetic influence on the phenotype of metastatic melanoma cells. This novel approach identifies specific genes involved in the transdifferentiation of melanocytes to a more aggressive phenotype, which may offer significant therapeutic value.
Similar articles
- Influence of the microenvironment on melanoma cell fate determination and phenotype.
Postovit LM, Seftor EA, Seftor RE, Hendrix MJ. Postovit LM, et al. Cancer Res. 2006 Aug 15;66(16):7833-6. doi: 10.1158/0008-5472.CAN-06-0731. Cancer Res. 2006. PMID: 16912153 Review. - Multiple complementary transcripts of pCMa1, a novel gene located at chromosome 11p15.1-2, and melanocytic cell transformation.
Meije CB, Das PK, Jans MM, Hau C, van der Wal AC, Alders M, Hakvoort TB, Weidle UH, Lamers WH, Swart GW. Meije CB, et al. J Pathol. 2002 Aug;197(5):668-76. doi: 10.1002/path.1152. J Pathol. 2002. PMID: 12210088 - Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB, Hakvoort TB, Swart GW, Westerhof W, Lamers WH, Das PK. Meije CB, et al. J Pathol. 2002 Jan;196(1):51-8. doi: 10.1002/path.1017. J Pathol. 2002. PMID: 11748642 - Tumor progression in the human melanocytic system.
Kath R, Rodeck U, Menssen HD, Mancianti ML, Linnenbach AJ, Elder DE, Herlyn M. Kath R, et al. Anticancer Res. 1989 Jul-Aug;9(4):865-72. Anticancer Res. 1989. PMID: 2554787 - Molecular correlates in the progression of normal melanocytes to melanomas.
Halaban R. Halaban R. Semin Cancer Biol. 1993 Jun;4(3):171-81. Semin Cancer Biol. 1993. PMID: 8318693 Review.
Cited by
- KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.
Huh SJ, Chen YL, Friedman SL, Liao J, Huang HJ, Cavenee WK, Robertson GP. Huh SJ, et al. J Natl Cancer Inst. 2010 Aug 4;102(15):1131-47. doi: 10.1093/jnci/djq218. Epub 2010 Jul 21. J Natl Cancer Inst. 2010. PMID: 20660366 Free PMC article. - Tumour vascularization: sprouting angiogenesis and beyond.
Hillen F, Griffioen AW. Hillen F, et al. Cancer Metastasis Rev. 2007 Dec;26(3-4):489-502. doi: 10.1007/s10555-007-9094-7. Cancer Metastasis Rev. 2007. PMID: 17717633 Free PMC article. Review. - Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor.
Memarzadeh S, Xin L, Mulholland DJ, Mansukhani A, Wu H, Teitell MA, Witte ON. Memarzadeh S, et al. Cancer Cell. 2007 Dec;12(6):572-85. doi: 10.1016/j.ccr.2007.11.002. Cancer Cell. 2007. PMID: 18068633 Free PMC article. - Exploiting the convergence of embryonic and tumorigenic signaling pathways to develop new therapeutic targets.
Abbott DE, Postovit LM, Seftor EA, Margaryan NV, Seftor RE, Hendrix MJ. Abbott DE, et al. Stem Cell Rev. 2007 Jan;3(1):68-78. doi: 10.1007/s12015-007-0010-x. Stem Cell Rev. 2007. PMID: 17873384 Review. - Matricellular proteins in cancer: a focus on secreted Frizzled-related proteins.
Vincent KM, Postovit LM. Vincent KM, et al. J Cell Commun Signal. 2018 Mar;12(1):103-112. doi: 10.1007/s12079-017-0398-2. Epub 2017 Jun 7. J Cell Commun Signal. 2018. PMID: 28589318 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical